Status:
RECRUITING
Evaluation of Patients With Immune Function Abnormalities
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Chronic Granulomatous Disease (CGD)
X-Linked Severe Combined Immune Deficiency (XSCID)
Eligibility:
All Genders
Brief Summary
This study will evaluate patients with abnormal immune function that results in recurrent or unusual infections or chronic inflammation. This may include inherited conditions, such as X-linked severe ...
Detailed Description
This protocol is designed for the screening and baseline assessment of and collection of research samples from patients with abnormalities of immune function as manifested by recurrent or unusual infe...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Patients:
- To be eligible to participate in this study as a patient, an individual must meet the following criteria:
- Must be 2 years of age to be seen at the Clinical Center as an outpatient and they must not have any active infections. Send-in samples for clinical diagnosis at any age.
- Have an abnormality of immune function as manifested by:
- recurrent or unusual infections,
- recurrent or chronic inflammation, or
- previous laboratory evidence of immune dysfunction.
- Have a primary physician outside of the NIH.
- Relatives of Patient:
- To be eligible to participate in this study as a patient relative, an individual must meet the following criteria:
- Be a biological mother, father, sibling, child, grandparent, aunt, uncle, or first cousin to a patient.
- -Sibling, child, first cousin, aunt, and uncle must be 2 years of age to be seen at the Clinical Center as an outpatient with no active infections, Send-in samples for clinical diagnosis at any age.
- Be willing to have blood stored for future studies and/or other research purposes.
- Healthy Volunteers:
- To be eligible to participate in this study as a healthy volunteer, an individual must meet the following criteria:
- Be a healthy adult of either sex and between age of 18 and 85 years old.
- Have a hemoglobin count of \>=11.
- Weight greater than 110 pounds.
- Not have a history of intravenous injection drug use.
- Not have a history of engaging in high-risk activities for exposure to HIV.
- Be willing to have their blood samples stored for future research and modified to iPS cells.
- EXCLUSION CRITERIA:
- Patients and Relatives of Patient:
- In general, there are no strict exclusion criteria for these cohorts. However, the presence of certain types of acquired abnormalities of immunity solely due to HIV, chemotherapeutic agent(s), or an underlying malignancy could be grounds for possible exclusion for a patient or relative of a patient. In the opinion of the investigator, the presence of such disease processes may interfere with evaluation of a co-existing abnormality of immunity that is the subject of study under this protocol. Pregnant females will not be allowed to participate in any procedure that may be dangerous to the pregnancy or the fetus.
- Healthy Volunteers:
- An individual who meets any of the following criteria will be excluded from participation as a healthy volunteer in this study:
- Have HIV or viral hepatitis (B or C), or history of viral hepatitis B or C since age 11.
- Receiving chemotherapeutic agent(s) or have underlying malignancy.
- Pregnant.
- Have history of heart, lung, kidney disease, or bleeding disorders.
Exclusion
Key Trial Info
Start Date :
September 19 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
3500 Patients enrolled
Trial Details
Trial ID
NCT00128973
Start Date
September 19 2005
Last Update
January 5 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892